Who Owns Pelthos Therapeutics Stock?
NYSE: PTHSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 42.26%
- Held by insiders
- 50.05%
- Institutional holders
- 27
- Institutions 42.3%
- Insiders 50.0%
- Public and other 7.7%
Who owns Pelthos Therapeutics stock?
Institutional investors own about 42.3% of Pelthos Therapeutics's shares, spread across 27 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 50.05% of PTHS.
The largest institutional holders are AIGH Capital Management LLC (8.60%), Murchinson Ltd. (7.95%) and Ikarian Capital, LLC (6.70%). Together, the top 10 institutions control 32.2% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their PTHS positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PTHS
| Institution | Shares | % Held | Change |
|---|---|---|---|
| AIGH Capital Management LLC | 329.10K | 8.60% | +100.0% |
| Murchinson Ltd. | 304.30K | 7.95% | +2.7% |
| Ikarian Capital, LLC | 256.60K | 6.70% | 0.0% |
| Boothbay Fund Management, LLC | 101.98K | 2.66% | +24.6% |
| Vanguard Capital Management LLC | 97.13K | 2.54% | +4.3% |
| Cantor Fitzgerald, L.P. | 38.12K | 1.00% | -8.0% |
| J. Goldman & Co., L.P. | 38.08K | 0.99% | -24.5% |
| Diadema Partners LP | 24.77K | 0.65% | 0.0% |
| Wexford Capital LP | 22.36K | 0.58% | +100.0% |
| Knott David M., Jr. | 22.07K | 0.58% | +4.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PTHS
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 78.01K | 2.04% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 16.13K | 0.42% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 7.70K | 0.20% |
| iShares Trust-iShares Micro-Cap ETF | 4.96K | 0.13% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 2.05K | 0.05% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 1.97K | 0.05% |
| VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd. | 1.82K | 0.05% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 1.18K | 0.03% |
| EQ Advisors Trust-1290 VT Micro Cap Portfolio | 333 | 0.01% |
Frequently asked questions
Who is the largest shareholder of Pelthos Therapeutics?
AIGH Capital Management LLC is the largest institutional shareholder of PTHS, owning 8.60% of shares outstanding (329.10K shares) as of its latest 13F filing.
What percentage of Pelthos Therapeutics is owned by institutions?
Institutions own about 42.3% of PTHS shares and 84.6% of the public float.
How much of Pelthos Therapeutics do insiders own?
Insiders, such as officers and directors, own about 50.05% of PTHS shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.